Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,963 public trials 2,020 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Recruiting

SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)

NCT07021495

Conditions
Abscess, Angioedema, Atopic Dermatitis (AD), +56 more
Locations
  • Radboud University Medical Center Nijmegen, Gelderland, Netherlands
  • Maastricht University Medical Center+ Maastricht, Limburg, Netherlands
  • Amsterdam University Medical Center Amsterdam, North Holland, Netherlands
  • University Medical Center Groningen Groningen, Provincie Groningen, Netherlands
View Trial Details
Recruiting

Study of ODX (OsteoDex) in Multiple Myeloma

NCT06616389

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Karolinska Universitetssjukhuset Huddinge Cancerstudieenheten M62 Stockholm, Sweden
  • Uddevalla Sjukhus, Hematologens dagvård Uddevalla, Sweden
View Trial Details
Recruiting

A Study of GLB-002 in Patients With Relapsed or Refractory Non-Hodgkin Lymphomas

NCT06219356

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
  • Sun Yat-Sen University Cancer Center Guangzhou, Guangdong, China
View all 13 locations
View Trial Details
Recruiting

SVRd for the Treatment of Newly Diagnosed Multiple Myeloma Patients Presenting With Extramedullary Disease

NCT05900882

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Changzhou Second People's Hospital Changzhou, Jiangsu, China
  • Nanjing First People's Hospital Nanjing, Jiangsu, China
  • The First Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, China
  • Affiliated Hospital of Nantong University Nantong, Jiangsu, China
View Trial Details
Recruiting

A Phase-3-trial of Acalabrutinib, Obinutuzumab & Venetoclax Compared to Obinutuzumab and Venetoclax in Previously Untreated Patients With High Risk CLL

NCT05197192

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Helios Klinikum Bad Saarow Bad Saarow, Germany
  • DRK Kliniken Berlin Köpenick Berlin, Germany
  • Ev. Diakoniekrankenhaus Bremen, Germany
  • Universitätsklinik Köln Cologne, Germany
View all 30 locations
View Trial Details
Recruiting

Response-adaptive to Epcoritamab In First Relapse: Study to Evaluate the Efficacy of Eptoritamab in Patients With Relapse/Refractory Large B Cell Lymphoma

NCT07126236

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • Hospital Universitario Miguel Servet Zaragoza, Aragon, Spain
  • Hospital Universitario de Burgos Burgos, Castille and León, Spain
  • ICO Badalona Badalona, Catalonia, Spain
  • Hospital Universitari Vall d'Hebrón Barcelona, Catalonia, Spain
View all 15 locations
View Trial Details

Related conditions